Company Filing History:
Years Active: 2019-2025
Title: Adriana Feder: Innovator in PTSD Treatment
Introduction
Adriana Feder is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of mental health, particularly in the treatment of post-traumatic stress disorder (PTSD). With a total of 3 patents, her work is paving the way for innovative therapeutic approaches.
Latest Patents
Feder's latest patents focus on methods of treating PTSD using ketamine. The first patent discloses compositions containing ketamine and outlines methods for using these compositions in the treatment of PTSD. Additionally, she has developed a pharmaceutical composition that includes esketamine, which is designed for intranasal or intravenous administration. This composition is intended for treating PTSD in subjects, as well as addressing major depressive disorder that may co-occur with PTSD.
Career Highlights
Adriana Feder is affiliated with the Icahn School of Medicine at Mount Sinai, where she conducts her research and develops her innovative treatments. Her work is recognized for its potential to transform the landscape of mental health treatment.
Collaborations
Feder collaborates with notable professionals in her field, including Dennis S. Charney, enhancing the impact of her research and innovations.
Conclusion
Adriana Feder's contributions to the treatment of PTSD through her innovative patents highlight her role as a leading inventor in mental health. Her work continues to inspire advancements in therapeutic methods for those affected by PTSD.